Julin Yang

524 total citations
31 papers, 418 citations indexed

About

Julin Yang is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Julin Yang has authored 31 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Julin Yang's work include Drug Transport and Resistance Mechanisms (14 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Julin Yang is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Julin Yang collaborates with scholars based in China, United States and Bahrain. Julin Yang's co-authors include Aiming Liu, Frank J. Gonzalez, Manyun Dai, Bin Guo, Zhen Tan, Danjun Song, Jinshun Zhao, Lu Sun, Zhong‐Ze Fang and Renke Dai and has published in prestigious journals such as The Science of The Total Environment, British Journal of Pharmacology and International Journal of Obesity.

In The Last Decade

Julin Yang

30 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julin Yang China 12 138 114 101 84 49 31 418
Shaodong Chen China 13 133 1.0× 37 0.3× 65 0.6× 117 1.4× 36 0.7× 52 505
Manar G. Helal Egypt 12 98 0.7× 73 0.6× 49 0.5× 79 0.9× 23 0.5× 26 395
Hanmin Li China 14 211 1.5× 78 0.7× 33 0.3× 100 1.2× 92 1.9× 36 588
Hamidreza Mohammadi Iran 16 126 0.9× 113 1.0× 89 0.9× 96 1.1× 114 2.3× 35 655
Arastoo Saeedi Iran 11 88 0.6× 88 0.8× 38 0.4× 59 0.7× 61 1.2× 16 456
Khadijeh Mousavi Iran 14 68 0.5× 93 0.8× 74 0.7× 56 0.7× 85 1.7× 20 409
Sreetama Choudhury India 9 136 1.0× 61 0.5× 25 0.2× 30 0.4× 13 0.3× 10 448
Hyung‐Seon Baek South Korea 8 109 0.8× 107 0.9× 32 0.3× 27 0.3× 15 0.3× 18 465
Sahar E. El-Swefy Egypt 14 77 0.6× 36 0.3× 33 0.3× 56 0.7× 39 0.8× 25 502

Countries citing papers authored by Julin Yang

Since Specialization
Citations

This map shows the geographic impact of Julin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julin Yang more than expected).

Fields of papers citing papers by Julin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julin Yang. The network helps show where Julin Yang may publish in the future.

Co-authorship network of co-authors of Julin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Julin Yang. A scholar is included among the top collaborators of Julin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julin Yang. Julin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ying, Jie Yang, Lei Jiang, et al.. (2024). PPARα suppresses low-intensity-noise-induced body weight gain in mice: the activated HPA axis plays an critical role. International Journal of Obesity. 48(9). 1274–1282.
2.
Yang, Jie, et al.. (2023). Exposure to low-intensity noise exacerbates nonalcoholic fatty liver disease by activating hypothalamus pituitary adrenal axis. The Science of The Total Environment. 906. 167395–167395. 11 indexed citations
3.
Kang, Jinyu, Shengtao Li, Yufei Song, et al.. (2022). Hepatocytic AP-1 and STAT3 contribute to chemotaxis in alphanaphthylisothiocyanate-induced cholestatic liver injury. Toxicology Letters. 373. 184–193. 5 indexed citations
4.
Dai, Manyun, Liping Xu, Haoyue Zhang, et al.. (2022). Down-regulation of hepatic CLOCK by PPARα is involved in inhibition of NAFLD. Journal of Molecular Medicine. 101(1-2). 139–149. 4 indexed citations
5.
Dai, Manyun, et al.. (2020). Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profile. International Journal of Molecular Medicine. 46(6). 2271–2279. 2 indexed citations
6.
Yang, Julin, et al.. (2020). PPARα mediates night neon light-induced weight gain: role of lipid homeostasis. Theranostics. 10(25). 11497–11506. 12 indexed citations
7.
8.
Kang, Jinyu, et al.. (2019). Schisandrin B and Schisandrol B induce mouse CYP2b10 associated with CAR not PXR. Phytochemistry Letters. 35. 164–170. 1 indexed citations
9.
Dai, Manyun, Xiaowei Hu, Liping Xu, et al.. (2018). Basal PPARα inhibits bile acid metabolism adaptation in chronic cholestatic model induced by α-naphthylisothiocyanate. Toxicology Letters. 300. 31–39. 8 indexed citations
10.
Dai, Manyun, Julin Yang, Danjun Song, et al.. (2017). Inhibition of JNK signalling mediates PPARα‐dependent protection against intrahepatic cholestasis by fenofibrate. British Journal of Pharmacology. 174(18). 3000–3017. 41 indexed citations
11.
Tan, Zhen, Manyun Dai, Danjun Song, et al.. (2016). Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity. Archives of Toxicology. 91(2). 897–907. 21 indexed citations
12.
Yang, Julin, Zhen Tan, Manyun Dai, et al.. (2016). Oral administration of nano-titanium dioxide particle disrupts hepatic metabolic functions in a mouse model. Environmental Toxicology and Pharmacology. 49. 112–118. 41 indexed citations
13.
Tan, Zhen, Julin Yang, Yuqing Cheng, et al.. (2016). Chlorogenic acid inhibits cholestatic liver injury induced by α-naphthylisothiocyanate: involvement of STAT3 and NFκB signalling regulation. Journal of Pharmacy and Pharmacology. 68(9). 1203–1213. 34 indexed citations
14.
Liu, Aiming, Naoki Tanaka, Lu Sun, et al.. (2014). Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling. Chemico-Biological Interactions. 223. 80–86. 70 indexed citations
15.
Liu, Aiming, et al.. (2014). In vivo induction of CYP in mice by carbamazepine is independent on PXR. Pharmacological Reports. 67(2). 299–304. 7 indexed citations
16.
Yang, Julin, Aiming Liu, Yuanyuan Han, et al.. (2013). Osteodifferentiation of mesenchymal stem cells on chitosan/hydroxyapatite composite films. Journal of Biomedical Materials Research Part A. 102(4). 1202–1209. 17 indexed citations
17.
Liu, Aiming, Julin Yang, Xiaoli Huang, et al.. (2012). Relaxation of rat thoracic aorta by fibrate drugs correlates with their potency to disturb intracellular calcium of VSMCs. Vascular Pharmacology. 56(3-4). 168–175. 7 indexed citations
18.
Guo, Bin, Zhong‐Ze Fang, Yun‐Feng Cao, et al.. (2012). Deglycosylation of Liquiritin Strongly Enhances its Inhibitory Potential Towards UDP‐Glucuronosyltransferase (UGT) Isoforms. Phytotherapy Research. 27(8). 1232–1236. 19 indexed citations
19.
Liu, Aiming, Julin Yang, Xin Zhao, et al.. (2011). Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats. Pharmacological Reports. 63(1). 157–164. 9 indexed citations
20.
Liu, Aiming, et al.. (2010). Biphasic Regulation of Intracellular Calcium by Gemfibrozil Contributes to Inhibiting L6 Myoblast Differentiation: Implications for Clinical Myotoxicity. Chemical Research in Toxicology. 24(2). 229–237. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026